Crossmark

The ITA.LI.CA Consortium: How multicentre collaboration helped shape the management of patients with hepatocellular carcinoma on the basis of real-world evidence

Crossref DOI link: https://doi.org/10.1016/j.aohep.2021.100564

Published Print: 2022-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Trevisani, Franco

Giannini, Edoardo G.
Funding

Funding for this research was provided by:

Meso Scale Diagnostics

Bayer

Gilead Sciences

Bristol-Myers Squibb

AstraZeneca

AbbVie
License Information

Text and Data Mining valid from 2022-01-01

Text and Data Mining valid from 2022-01-01

Version of Record valid from 2021-10-13
More Information

This article is maintained by: Elsevier

Article Title: The ITA.LI.CA Consortium: How multicentre collaboration helped shape the management of patients with hepatocellular carcinoma on the basis of real-world evidence

Journal Title: Annals of Hepatology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.aohep.2021.100564

Content Type: article

Copyright: © 2021 Published by Elsevier España, S.L.U. on behalf of Fundación Clínica Médica Sur, A.C.

Document is current

Any future updates will be listed below